1. Home
  2. GAIA vs LUNG Comparison

GAIA vs LUNG Comparison

Compare GAIA & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$2.08

Market Cap

70.9M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.43

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
LUNG
Founded
1988
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
57.9M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
GAIA
LUNG
Price
$2.08
$1.43
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$6.50
$5.38
AVG Volume (30 Days)
290.8K
568.9K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
7.64
EPS
N/A
N/A
Revenue
$4,500,000.00
$90,497,000.00
Revenue This Year
$13.07
$2.48
Revenue Next Year
$12.04
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
12.50
8.01
52 Week Low
$2.03
$1.13
52 Week High
$6.39
$3.88

Technical Indicators

Market Signals
Indicator
GAIA
LUNG
Relative Strength Index (RSI) 36.13 50.96
Support Level N/A $1.22
Resistance Level $2.68 $1.45
Average True Range (ATR) 0.15 0.12
MACD -0.03 0.01
Stochastic Oscillator 8.24 53.12

Price Performance

Historical Comparison
GAIA
LUNG

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: